BR2161 : Breast cancer tissue array, including TNM and pathology grade, 216 cases/216 cores
  • $455.00
Microarray Panel Breast carcinoma tissue microarray, containing 189 cases of breast invasive ductal carcinoma, 1 breast papillary carcinoma, 4 breast invasive lobular carcinoma, 1 breast mixed invasive lobular and ductal carcinoma, 2 breast mucinous carcinoma, 1 each of breast apocrine carcinoma and breast adenoid cystic carcinoma, 6 breast medullary carcinoma, 1 each of breast squamous cell carcinoma, neuroendocrine carcinoma and lipid-rich carcinoma plus 7 cancer adjacent breast normal tissue and 1 normal breast tissue, single core per case
Cores 216
Biomax.us Tissue Array BR2161
Cases 216
Row number 12
Column number 18
Core Diameter (mm) 1
Thickness (µm) 5
QA/QC Anti-Actin confirmed
Tissue Array Type FFPE
Species Human
Applications Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers.
Mouseover and click individual cores to view high resolution images.
Slide Label: US Biomax, Inc. Tissue Array
123456789101112131415161718 
ABreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
BBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
CBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
DBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
EBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
FBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
GBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
HBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
IBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
JBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
KBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBre 
LBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreBreMarked point
Legend: Bre - Breast

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IV), - NAT, - Normal tissue

Specification Sheet (Sortable), tissue IDs are available in exported Excel files.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: